Search company, investor...
Tempus company logo

Tempus

tempus.com

Founded Year

2015

Stage

Unattributed - II | Alive

Total Raised

$1.345B

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+30 points in the past 30 days

About Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine-learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions. It serves clients in the healthcare sector. The company was founded in 2015 and is based in Chicago, Illinois.

Headquarters Location

600 West Chicago Avenue Suite 510

Chicago, Illinois, 60654,

United States

833-514-4187

ESPs containing Tempus

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Health Data & Analytics

The real-world data market refers to the collection and analysis of data from various sources, including electronic health records, claims data, and patient-generated data. This data is used to provide insights into real-world patient outcomes, treatment patterns, and disease progression. The market offers solutions that can help healthcare stakeholders make informed decisions about drug developme…

Tempus named as Leader among 15 other companies, including Datavant, Truveta, and Aetion.

Compete with Tempus?

Ensure that your company and products are accurately represented on our platform.

Tempus's Products & Differentiators

    Sequencing

    Use our genomic platform to prospectively sequence through clinical trials and retrospectively support research priorities

Expert Collections containing Tempus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tempus is included in 17 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,208 items

A

AI 100

99 items

C

Clinical Trials Tech

341 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

A

Artificial Intelligence

10,624 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

Tempus Patents

Tempus has filed 116 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Genetics
  • Oncology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/17/2019

5/2/2023

Biological databases, Biotechnology, DNA sequencing, Genomics, Oncology

Grant

Application Date

10/17/2019

Grant Date

5/2/2023

Title

Related Topics

Biological databases, Biotechnology, DNA sequencing, Genomics, Oncology

Status

Grant

Latest Tempus News

TempusDirect Joins the CCC Network to Deliver Third-Party Casualty Solutions

May 4, 2023

CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Inc. (CCC), a leading cloud platform powering the P&C insurance economy, announces today that TempusDirect (Tempus), an innovation leader in repricing services for third-party medical billing, is the newest company to integrate into the CCC Network. CCC Casualty customers will be able to perform medical bill review in CCC’s Injury Evaluation Solutions (IES) offering and seamlessly refer medical bills to Tempus for a variety of services. Re

Tempus Frequently Asked Questions (FAQ)

  • When was Tempus founded?

    Tempus was founded in 2015.

  • Where is Tempus's headquarters?

    Tempus's headquarters is located at 600 West Chicago Avenue, Chicago.

  • What is Tempus's latest funding round?

    Tempus's latest funding round is Unattributed - II.

  • How much did Tempus raise?

    Tempus raised a total of $1.345B.

  • Who are the investors of Tempus?

    Investors of Tempus include Ares Management, T. Rowe Price, Baillie Gifford & Co., Novo Holdings, Franklin Templeton and 8 more.

  • Who are Tempus's competitors?

    Competitors of Tempus include Deep Lens, Holmusk, nference, Lunit, Sapient, NuProbe, Perthera, Zephyr AI, Helix, First Ascent Biomedical and 25 more.

  • What products does Tempus offer?

    Tempus's products include Sequencing and 4 more.

  • Who are Tempus's customers?

    Customers of Tempus include AstraZeneca, GSK, Genmab and Bayer.

Compare Tempus to Competitors

ConcertAI Logo
ConcertAI

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

Owkin Logo
Owkin

Owkin specializes in artificial intelligence technologies applied to clinical research and developing drugs and treatments for patients. The company empowers researchers in hospitals, universities, and the biopharma industry to understand drug efficacy varies, improve the drug development process, and help identify key drugs and treatments for individual patients to improve patient outcomes. The company delivers a medicine platform that aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The company was founded in 2016 and is based in New York, New York.

Aetion Logo
Aetion

Aetion is a healthcare analytics company delivering real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. The company was founded in 2013 and is based in New York, New York.

Evidation Logo
Evidation

Evidation operates as a multichannel health tracking platform. It enables users to connect with multiple appications to track everyday activity and earn rewards for steps, sleep, surveys, and more. The company was founded in 2012 and is based in San Mateo, California.

Nuna Logo
Nuna

Nuna is a healthcare technology company that seeks to help make high-quality healthcare affordable and accessible for everyone. The company does this by building data solutions for healthcare payers and providers to measure and improve their cost and quality outcomes.

Optum Logo
Optum

Optum (NYSE: UNH) is an information and technology-enabled health services business. The company delivers integrated solutions that help to modernize the health system and improve overall population health. Through Optum Care, the company offers a network of doctors nationwide. Optum Financial provides financing and payment services, expanding access to care in the health system. Additional offerings include Optum Rx, Optum Perks, Optum Bank, as well as a number of sites for health care professionals. The company was founded in 2011 and is based in Eden Prairie, Minnesota.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.